Literature DB >> 14411872

The determination of antigenic potency of poliomyelitis vaccine by measuring its antibody-combining capacity.

U KRECH.   

Abstract

A modification is described of the antibody-combining test originally introduced by the author in 1955. The reaction between antigen and antibody has been shown to be type specific, reproducible and relatively precise if the plaque technique is used for the titration of infective virus. Though the data available at present suggest that the antibody-combining capacity of a vaccine as titrated by this method parallels the antigenic activity measured in vivo, more information is necessary to give conclusive evidence on the relation between antigenic potencies titrated in vitro and in vivo.

Entities:  

Keywords:  POLIOMYELITIS/immunology

Mesh:

Substances:

Year:  1960        PMID: 14411872      PMCID: PMC2555327     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  Neutralizing-antibody-combining (NAC) test for measuring antigenic potency of poliomyelitis vaccine.

Authors:  M BENYESH-MELNICK; J L MELNICK
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

2.  [Manometric demonstration of the Dulbecco-Krech phenomenon].

Authors:  G CAVALLO; R HAAS
Journal:  Riv Ist Sieroter Ital       Date:  1956 May-Jun

3.  Use of vinyl plastic containers in tissue cultures for virus assays.

Authors:  W A RIGHTSEL; P SCHULTZ; D MUETHING; I W MCLEAN
Journal:  J Immunol       Date:  1956-06       Impact factor: 5.422

4.  Preparation and standardization of antiserums prepared with the three known types to poliomyelitis viruses.

Authors:  H A WENNER; C A MILLER; P KAMITSUKA; J C WILSON
Journal:  Am J Hyg       Date:  1954-03

5.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

6.  The antigenic potency of non-infectious poliomyelitis virus as determined by its liberating effect on active virus neutralized by immune serum.

Authors:  U KRECH
Journal:  J Exp Med       Date:  1955-03-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.